Lipoprotein(a) Levels and the Risk of Coronary Heart Disease and Stroke: The Suita Study
Lp(a) ≥ 30 mg/dL was associated with an increased risk of CHD in the Japanese population.
Authors
- Yu Kataoka (ORCID: https://orcid.org/0000-0001-6307-5593)
- Paramita Khairan (ORCID: https://orcid.org/0000-0002-9235-0707)
- Yoshihiro Kokubo (ORCID: https://orcid.org/0000-0002-0705-9449)
- Ahmed Arafa (ORCID: https://orcid.org/0000-0002-3335-2243)
- Mariko Harada‐Shiba (ORCID: https://orcid.org/0000-0002-7600-2059)
- Yoko M. Nakao (ORCID: https://orcid.org/0000-0002-3627-5626)
- Chisa Matsumoto (ORCID: https://orcid.org/0000-0002-8066-8363)
- Yuka Kato (ORCID: https://orcid.org/0009-0009-2739-9609)
Institutions
- Beni-Suef University (EG)
- Tokyo Medical University Hospital (JP)
- National Cerebral and Cardiovascular Center (JP)
- Universitas Muhammadiyah Jakarta (ID)
- Osaka University of Pharmaceutical Sciences (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Journal of Atherosclerosis and Thrombosis
- Published
- 2025-03-29
- DOI
- https://doi.org/10.5551/jat.65437
- Citations
- 1
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- Eli Lilly and Company
- National Cerebral and Cardiovascular Center
- Japan Society for the Promotion of Science